Report

Global Market Study: Human Rabies vaccines - 2020

In addition to providing the most up-to date understanding of the current and future trajectory of global supply and demand of rabies vaccines for PrEP and PEP,8

this study identifies actions to help address the anticipated market dynamics and serves as an important resource for the implementation of the Zero by 30 strategy.

Languages

  • English

Publication year

2020

Publisher

WHO

Type

Report

Categories

  • Programme management

Diseases

  • Rabies

Tags

  • MI4A
  • Planning, budgeting and financing

Topic references

EPI-CORE-MI4A

TitleAuthorYearTypeLanguage
Global Market Study: BCG Vaccine - May 2019World Health Organization (WHO)2019ReportEnglish
Global Market Study: Diphtheria and tetanus-containing vaccines - 2019World Health Organization (WHO)2019ReportEnglish
Global Market Study: HPV - 2020World Health Organization (WHO)2020ReportEnglish
Global Market Study: Human Rabies vaccines - 2020World Health Organization (WHO)2020ReportEnglish
Global Market Study: Measles-containing vaccines (MCV) - 2020World Health Organization (WHO)2020ReportEnglish
Global Market Study: Meningococcal meningitis vaccines - 2019World Health Organization (WHO)2019ReportEnglish
Global Market Study: Pneumococcal Conjugate (PCV) and Polysaccharide (PPV) vaccines - 2020World Health Organization (WHO)2020ReportEnglish
Global Market Study: Typhoid vaccines - 2020World Health Organization (WHO)2020ReportEnglish
Global Vaccine Market Report - 2020World Health Organization (WHO)2020ReportEnglish
MI4A Project OverviewWorld Health Organization (WHO)GuidanceEnglish
MI4A Vaccine Purchase Data for Countries - 2022World Health Organization (WHO)DatasheetEnglish
Vaccine Price Report - 2017World Health Organization (WHO)2017ReportEnglish
Vaccine Pricing: Gavi Fully Self Financing and Accelerated Transition CountriesWorld Health Organization (WHO)2018ReportEnglish